Fc receptor inhibition reduces susceptibility to oxidative stress in human RPE cells treated with bevacizumab, but not aflibercept

Mahdy Ranjbar, Max Philipp Brinkmann, Dorinja Zapf, Yoko Miura, Martin Rudolf, Salvatore Grisanti

21 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Fc receptor inhibition reduces susceptibility to oxidative stress in human RPE cells treated with bevacizumab, but not aflibercept'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science